Exclusion Criteria:~1. Current evidence of other causes of dementia.. .~2. History of, or evidence of, active
malignancy, except for basal cell carcinoma or squamous cell carcinoma of the skin, within the 24 months prior
to entry. Men with prostate cancer may be enrolled at the discretion of the sponsor.~3. Use of any
investigational therapy within 30 days, or 5 half-lives, whichever is longer, and/or use of AD immunotherapy
prior to screening.~4. Major surgery and related complications not resolved within 12 weeks prior to Day 1.~5.
Previous participation in an MPC-7869 clinical study.
